NASDAQ / LIVE COMPANY INTELLIGENCE

Invivyd, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERIVVD
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / IVVD COVERAGE

What’s moving Invivyd, Inc. now

Current reporting with the operating signal separated from the noise.

01
Invivyd, Inc. (IVVD): Advancing RSV Antibody VBY329 Amid Analyst Downgrade

Invivyd, Inc. (IVVD): Advancing RSV Antibody VBY329 Amid Analyst Downgrade

The story matters when it changes Invivyd, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Invivyd, Inc. (IVVD) Q3 2025 Earnings Call Transcript

Invivyd, Inc. (IVVD) Q3 2025 Earnings Call Transcript

Investors are testing whether Invivyd, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID Prevention Transcript

Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID Prevention Transcript

The story matters when it changes Invivyd, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Invivyd, Inc. Reports 48% Q4 Revenue Growth for PEMGARDA™ and Advances Next-Generation Antibody VYD2311

Invivyd, Inc. Reports 48% Q4 Revenue Growth for PEMGARDA™ and Advances Next-Generation Antibody VYD2311

Investors are testing whether Invivyd, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Invivyd, Inc. Reports Preliminary Q4 2024 Financial Results with 48% Revenue Growth and Significant Cost Reductions

Invivyd, Inc. Reports Preliminary Q4 2024 Financial Results with 48% Revenue Growth and Significant Cost Reductions

Investors are testing whether Invivyd, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
Why Invivyd, Inc. (IVVD) Is Among the Best Penny Stocks to Invest In According to Media?

Why Invivyd, Inc. (IVVD) Is Among the Best Penny Stocks to Invest In According to Media?

Investors are testing whether Invivyd, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest IVVD filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-14 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-05 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-24 · Period 2026-07-23SEC ↗8-KMaterial company eventFiled 2026-07-06 · Period 2026-07-06SEC ↗8-KMaterial company eventFiled 2026-05-19 · Period 2026-05-19SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-06 · Period 2026-05-19SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-07-28SEC ↗
EARNINGS / QUARTERLY TRACKER

Invivyd, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.

Q4

Fourth quarter / full year

SEARCH Q4 COVERAGE →